Restylane Refyne
Restylane Refyne is a dermal tissue reconstructive material (FDA Class III; FDA product code LMH, Implant, Dermal, For Aesthetic Use) made by Acre Pharma Limited, listed in FDA GUDID since 19 Nov 2020 (UDI-DI 05060604130096), registry data as of 22 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05060604130096 | Date19 Nov 2020 | StatusListed |
Official records
- AccessGUDID record 05060604130096
From the FDA record
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Generic name
- Dermal tissue reconstructive material, animal-derived
- Primary DI / UDI-DI
- 05060604130096
- FDA product code
- LMH
- GMDN term
- Dermal tissue reconstructive material, animal-derived
- Device class
- Class III
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code LMH (Implant, Dermal, For Aesthetic Use).
- PREVELLE SILK by Genzyme Biosurgery
- HYDRELLE by Anika Therapeutics, Inc.
- Sculptra and Sculptra Aesthetic by Q-Med AB
- Radiesse Dermal Filler by Merz North America, Inc.
- Restylane Injectable Gel by Q-Med AB
- Revanesse Versa+ by Prollenium Medical Technologies Inc.
- saypha® ChiQ™ by Croma-Pharma GmbH
- Juvéderm Voluma XC by Allergan
- Radiesse Injectable Implant by Merz North America, Inc.
- Evolence Collagen Filler by Colbar Lifescience, Ltd.